Published in Immunol Ser on January 01, 1994
Role of nitric oxide in parasitic infections. Microbiol Rev (1995) 1.91
Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology (1996) 1.31
Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun (1998) 1.29
Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect Immun (2001) 1.15
Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect Immun (1997) 1.06
Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection. Infect Immun (1999) 1.04
Role of nitric oxide in host defense against an extracellular, metazoan parasite, Brugia malayi. Infect Immun (1996) 1.04
Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo. Immunology (1996) 0.99
IL-17A synergizes with IFN-γ to upregulate iNOS and NO production and inhibit chlamydial growth. PLoS One (2012) 0.94
T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development. Can J Infect Dis (1998) 0.94
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword. Front Immunol (2014) 0.85
Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis. Infect Immun (2005) 0.83
Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis. Clin Exp Immunol (2001) 0.81
Expression of NO-synthase in cells of foreign-body and BCG-induced granulomata in mice: influence of L-NAME on the evolution of the lesion. Immunology (1998) 0.81
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science (1987) 8.98
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 6.93
Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 6.92
Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol (1990) 4.62
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol (1990) 4.36
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Control of carcinogenesis: a possible role for the activated macrophage. Science (1972) 3.69
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest (1988) 3.69
Sarcopenia. J Lab Clin Med (2001) 3.41
EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci U S A (1990) 2.94
Macrophage tumor killing: influence of the local environment. Science (1977) 2.94
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (1994) 2.86
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76
Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol (1978) 2.65
Urinary nitrate excretion in relation to murine macrophage activation. Influence of dietary L-arginine and oral NG-monomethyl-L-arginine. J Immunol (1991) 2.60
Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis (1971) 2.58
Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril (1998) 2.57
Computerised updating of clinical summaries: new opportunities for clinical practice and research? BMJ (1988) 2.49
Natural course of acute pancreatitis. World J Surg (1997) 2.48
Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance. Nat New Biol (1972) 2.44
L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae. J Immunol (1991) 2.15
Macrophage nonimmunologic recognition: target cell factors related to contact inhibition. Science (1973) 2.09
Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone. Clin Infect Dis (1992) 1.97
Nitric oxide produced during murine listeriosis is protective. Infect Immun (1994) 1.93
Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J Immunol (1993) 1.88
An almost-intact human endogenous retrovirus K on human chromosome 7. Nat Genet (1999) 1.87
Heterocytolysis by macrophages activated by bacillus Calmette-Guérin: lysosome exocytosis into tumor cells. Science (1974) 1.85
Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell (1982) 1.84
Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration. J Clin Invest (1980) 1.82
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med (1990) 1.80
The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J Leukoc Biol (1988) 1.72
Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst (1994) 1.72
Effect of coffee on glucose tolerance and circulating insulin in men with maturity-onset diabetes. Lancet (1967) 1.72
Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol (1996) 1.67
Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J Natl Cancer Inst (1974) 1.64
Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem Biophys Res Commun (1984) 1.64
Three years of in vitro fertilization at Norfolk. Fertil Steril (1984) 1.62
Endogenous retroviruses and cancer. Cell Mol Life Sci (2008) 1.55
Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect. Nature (1977) 1.55
Activity, calorie intake, fat storage, and the energy balance of infants. Pediatrics (1968) 1.51
Comparison of MIDI Sherlock system and pulsed-field gel electrophoresis in characterizing strains of methicillin-resistant Staphylococcus aureus from a recent hospital outbreak. J Clin Microbiol (1995) 1.51
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect Immun (1993) 1.50
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia (2009) 1.47
Differences in cancer-risk-related behaviors in Latino and Anglo adults. Prev Med (1991) 1.47
Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J Leukoc Biol (1988) 1.46
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med (1993) 1.44
Slippery surfaces of pitcher plants: Nepenthes wax crystals minimize insect attachment via microscopic surface roughness. J Exp Biol (2010) 1.43
MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun (2009) 1.43
Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene (2000) 1.40
[Hemophagocytic syndrome (case report and literature review)]. Vnitr Lek (2003) 1.40
Who cares? A focus group study on follow up care after discharge from hospital. Aust Fam Physician (2000) 1.40
[Invasive aspergillosis in hematooncological patients: advantages and disadvantages of various diagnostic methods, treatment options and financial costs of therapy]. Vnitr Lek (2008) 1.39
Bone marrow as multidimensional orbit oscillator after autologous bone marrow transplantation. Stem Cells (1999) 1.39
[IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review]. Vnitr Lek (2009) 1.39
[Heart transplantation and the subsequent treatment of AL amyloidosis]. Vnitr Lek (2013) 1.39
[Molecular pathogenesis of chronic lymphocytic leukemia with emphasis on cell cycle regulation and apoptosis]. Cas Lek Cesk (2004) 1.39
[The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients]. Vnitr Lek (2008) 1.39
[Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma]. Vnitr Lek (2010) 1.39
[Early diagnosis of invasive fungal infections in hematooncological patients by serological methods]. Vnitr Lek (2007) 1.38
[Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005]. Vnitr Lek (2006) 1.37
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol (1994) 1.37
Regulation of food intake and obesity. Science (1967) 1.35
Modulation of macrophage tumoricidal capability by components of normal serum: a central role for lipid. Science (1977) 1.35
Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol (1999) 1.31
In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages. Proc Soc Exp Biol Med (1972) 1.30
Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: evidence for high sequence conservation of human blood-derived BDV RNA. J Virol (1996) 1.29
Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin Infect Dis (2000) 1.28
Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7. Genomics (2001) 1.28
Assembly and regulation of NADPH oxidase and nitric oxide synthase. Curr Opin Immunol (1994) 1.24
A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev (1995) 1.21
HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2). J Virol (2001) 1.20
Aconitases: a class of metalloproteins highly sensitive to nitric oxide synthesis. Methods Enzymol (1996) 1.19
The macrophage as an antineoplastic surveillance cell: biological perspectives. J Reticuloendothel Soc (1978) 1.15
TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations. Leukemia (2010) 1.15
The role of nitrogen oxides as effector molecules of parasite killing. Parasitol Today (1990) 1.15
Modulation of macrophage tumoricidal capability by polyene antibiotics: support for membrane lipid as a regulatory determinant of macrophage function. Proc Natl Acad Sci U S A (1978) 1.14
Glucostatic mechanism of regulation of food intake. 1953. Obes Res (1996) 1.12
Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses (1999) 1.12
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib. Leukemia (2013) 1.11
Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection: impact of cleavage status, morphology grade, and number of embryos transferred. Fertil Steril (1999) 1.11
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect Immun (1995) 1.11
Adjuvant induced resistance to tumor development in mice. Proc Soc Exp Biol Med (1972) 1.10
Recommendations for toxicological investigations of drug-facilitated sexual assaults. J Forensic Sci (1999) 1.09
Species-specific identification of a wide range of clinically relevant fungal pathogens by use of Luminex xMAP technology. J Clin Microbiol (2009) 1.08
Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28- and CD8+CD28- T cells in rheumatoid arthritis. J Rheumatol (1999) 1.08
[Control of canine visceral leishmaniasis: comparison of results from a rapid elimination program of serum-reactive dogs using an immunoenzyme assay and slower elimination of serum-reactive dogs using filter paper elution indirect immunofluorescence]. Rev Soc Bras Med Trop (1998) 1.08
A comparative analysis of embryo implantation potential in patients with severe teratozoospermia undergoing in-vitro fertilization with a high insemination concentration or intracytoplasmic sperm injection. Hum Reprod (1996) 1.07
Fluconazole failure in the treatment of invasive mycoses. J Infect Dis (1991) 1.07
Toward an HIV type 1 vaccine that generates potent, broadly cross-reactive neutralizing antibodies. AIDS Res Hum Retroviruses (1999) 1.07
Activated macrophages as cytotoxic effector cells. Transplantation (1975) 1.07
Impact of different clinical variables on pregnancy outcome following embryo cryopreservation. Mol Cell Endocrinol (2000) 1.06
Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant (2005) 1.05
Some aspects of the problem of regulation of food intake and obesity. N Engl J Med (1966) 1.04